A PYMNTS Company

China/EU: Lobby slams China’s supposed discrimination against foreign firms

By  |  September 5, 2013

A business lobby in the European Union decried China’s alleged discrimination against foreign firms, specifically in the pharmaceutical market, describing the recent crackdown on non-domestic companies for competition violations as unfair.

Bruno Gensburger, the head of the EU’s Chamber of Commerce in China’s pharmaceutical working group, told reporters Thursday that China has been unfairly targeting companies, stating that, to his knowledge, “no Chinese company has been investigated.”

China denied claims regulators are discriminating their competition probes against foreign firms.

Recent months have shown Chinese regulators to be strengthening their grip on anticompetitive behavior. The largest such instance now is UK-based GlaxoSmithKline, which Chinese regulators have accused of anticompetitive behavior to boost its drug sales.

Full Content: Reuters

Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.